Jazz Pharmaceuticals (JAZZ) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 234.66 +4.92 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.74 | 52 Week High | $160.00 | |||
| Open | $233.23 | 52 Week Low | $95.80 | |||
| Day High | $234.68 | P/E | 43.62 | |||
| Day Low | $228.45 | EPS | $5.38 | |||
| Volume | 896,517 | |||||
